newsfilter
← Latest News
GlobeNewswire·

Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company's Board of Directors

FREDERICK, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the "Company"), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that